MDUFA IV Makeover For US FDA Guidances

The US agency detailed new review performance goals and user-fee policies to mark the start of a new fiscal year and five-year user-fee program.

FDA entrance sign 2016

Fiscal year 2018 is upon us and that means the recently enacted MDUFA IV user-fee program, including increased fees and enhanced review performance goals, is in effect.

To mark the occasion, US FDA on Oct. 2 updated its suite of review clock and user-fee guidance documents for...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation